RVVTF
Revive Therapeutics Ltd.
Set alert
0.01 USD 0.00 -6.67%
0.014 Day range 0.0146
0.007 52-week range 0.052
- YTD
- +75.00%
- 1 year
- +40.00%
- Open
- 0.0146
- Prev close
- 0.015
- Mkt cap
- 6.10M
- Vol
- 82.50K
- Avg vol
- 167.01K
- EPS
- -0.02
- P/E
- 0.00
More statistics
- Low
- 0.014
- High
- 0.0146
News
- Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
- Revive Therapeutics Announces Proposed Shares for Debt Settlement
- Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
- Revive Therapeutics Reports Grant of Options
- Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study
- Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
- Revive Therapeutics Announces Proposed Private Placement
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Your note
Sign in to keep a note on RVVTF — it syncs with the Stock Master app.